AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2016
May 5, 2016
32227_dirs_2016-05-04_4127d1f5-6d80-4b54-af4c-e8a9cb103348.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-04-20
Reporting Person: HANNAH ALISON L. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-20 | Common Stock | A | 2150 | $7.15 | Acquired | 13710 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 11560 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.66 | 2020-07-15 | Common Stock (10000) | 10000 | Direct |
Footnotes
F1: Alison Hannah received 2,150 restricted shares on April 20, 2016 for her service on the board of directors. These shares will vest ratably over each of the next four quarters at 537.5 shares per quarter.
F2: On July 15, 2015 Alison Hannah was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24